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ABSTRACT Most bacterial cells are enclosed in a single macromolecule of the cell wall polymer, peptidoglycan, which is required
for shape determination andmaintenance of viability, while peptidoglycan biosynthesis is an important antibiotic target. It is
hypothesized that cellular enlargement requires regional expansion of the cell wall through coordinated insertion and hydrolysis
of peptidoglycan. Here, a group of (apparent glucosaminidase) peptidoglycan hydrolases are identified that are together required
for cell enlargement and correct cellular morphology of Staphylococcus aureus, demonstrating the overall importance of this
enzyme activity. These are Atl, SagA, ScaH, and SagB. The major advance here is the explanation of the observed morphological
defects in terms of the mechanical and biochemical properties of peptidoglycan. It was shown that cells lacking groups of these
hydrolases have increased surface stiffness and, in the absence of SagB, substantially increased glycan chain length. This indi-
cates that, beyond their established roles (for example in cell separation), some hydrolases enable cellular enlargement by mak-
ing peptidoglycan easier to stretch, providing the first direct evidence demonstrating that cellular enlargement occurs via modu-
lation of the mechanical properties of peptidoglycan.
IMPORTANCE Understanding bacterial growth and division is a fundamental problem, and knowledge in this area underlies the
treatment of many infectious diseases. Almost all bacteria are surrounded by a macromolecule of peptidoglycan that encloses the
cell andmaintains shape, and bacterial cells must increase the size of this molecule in order to enlarge themselves. This requires
not only the insertion of new peptidoglycanmonomers, a process targeted by antibiotics, including penicillin, but also breakage
of existing bonds, a potentially hazardous activity for the cell. Using Staphylococcus aureus, we have identified a set of enzymes
that are critical for cellular enlargement. We show that these enzymes are required for normal growth and define the mechanism
through which cellular enlargement is accomplished, i.e., by breaking bonds in the peptidoglycan, which reduces the stiffness of
the cell wall, enabling it to stretch and expand, a process that is likely to be fundamental to many bacteria.
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In almost all bacteria, the major stress-bearing component of thecell envelope is a single, polymeric macromolecule of pepti-
doglycan. In order for an individual cell to grow (enlarge), new
monomeric precursors are added to the peptidoglycan sacculus.
These are inserted by penicillin binding proteins (PBPs), guided
by a complex machinery involving many components (1). How-
ever, enlargement of the sacculus cannot occur solely through the
addition of newmaterial. Existing bondsmust be cut in order that
the sacculus can permanently expand via accommodation ofmore
material. This activity is executed by peptidoglycan hydrolases.
These break specific amide and glycosidic bonds in the sacculus,
prompting the idea that some of these enzymes are required for
the enlargement of individual bacterial cells and, consequently,
for bacterial population growth.
While there is likely to be great variation in cellular enlarge-
ment mechanisms across the array of bacterial species, there is a
broadly held assumption that new peptidoglycan monomers are
inserted such that they do not initially experience stress derived
from turgor pressure. The idea is that stress is subsequently placed
on this new material due to the breaking of bonds within older
peptidoglycan, allowing the sacculus as a whole to expand. While
completely reasonable and therefore widely accepted, this as-
sumption is largely unsupported by experimental evidence. This
concept underpins the twomajor models of cellular enlargement,
one of which is for elongation of rod-shaped Gram-positive spe-
cies and the other for Escherichia coli. In rod-shaped Gram-
positive bacteria, “inside-to-outside growth” is proposed (2).New
monomers are applied at a high surface density close to the inner
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surface of the cell wall (the only region accessible to the
membrane-bound PBPs). As subsequent layers are added, the
older material is enzymatically degraded, causing stress to be ap-
plied to the newmaterial and the sacculus to expand. In E. coli, the
“three for one” model states that three new peptidoglycan mono-
mers are added in a loop around an existing monomer (3). When
the bonds attaching the existing monomer to its neighbors are
broken, stress is applied to the new loop, enabling expansion of the
sacculus. While they differ in detail, both of these models invoke
breaking of bonds within peptidoglycan and, thus, hydrolase ac-
tivity.
The necessity of hydrolases in cellular enlargement models
suggests that removing hydrolase activity should arrest this pro-
cess, causing the cell to stop dividing and ultimately terminating
the growth of the population, but surprisingly, there is only one
example of a hydrolase-encoding gene that is individually essen-
tial for survival, pcsB in Streptococcus pneumoniae (4, 5). However,
there are groups of hydrolases that are synthetically essential. In
Bacillus subtilis, removal of YvcE (CwlO) and LytE terminates cell
elongation and, thus, population growth (6), and in E. coli, loss of
Spr, YdhO, and YebA leads to an increasingly ellipsoid cell shape
and synthetic lethality (7). The existence of individually or collec-
tively essential hydrolases in these diverse species strongly suggests
a general phenomenon applicable to many other bacteria: that
bacterial cellular enlargement and thus, ultimately, division and
population growth depend on the ability of cells to hydrolyze pep-
tidoglycan (8). However, the detailed mechanisms by which hy-
drolysis enables individual cells to enlarge remain unclear.
In many species of bacteria, including E. coli, B. subtilis, and
S. pneumoniae, cellular enlargement is accomplished by two ma-
chineries (groups of proteins that work together to execute a cel-
lular process), one for elongation and another for division (9). In
these species, hydrolases can potentially be attributed separately to
either of these machineries (10). Staphylococcus aureus presents a
simplified system in which to study the role of hydrolases in cell
enlargement, as it is roughly spherical and does not have a specific
elongation machinery. Insertion of peptidoglycan apparently oc-
curs only during septation (11, 12), while cell volume increases at
a constant rate throughout the cell cycle (13), before the process is
repeated on a plane orthogonal to the two previous divisions (14).
The septal disc is initially protected from the level of turgor-
induced stress experienced by the rest of the cell wall, as it is
formed inside the cell. For this reason and the absence of a preex-
isting layer of cell wall at the beginning of septation, the inside-to-
outside-growthmodel cannot be applied.Maturation of the septal
disc is accompanied by alterations in peptidoglycan architecture
and mechanical properties. The nanoscale surface architecture of
the peptidoglycan changes from a ring like (15) to a knobbly
(punctate) pattern (11). This is accompanied by changes in the
stiffness of the cell surface; Atomic Force Microscopy (AFM) has
shown that recently revealed septal cell wall is stiffer than mature
cell wall (16).
S. aureus has numerous genes encoding peptidoglycan hydro-
lases (17–19). Here, we focus on N-acetylglucosaminidases (glu-
cosaminidases), a class of cell wall hydrolases that target the bond
between theN-acetylglucosamine andN-acetylmuramic acid res-
idues in the polysaccharide (glycan) backbone of peptidoglycan.
S. aureus has very short glycan strands compared to many other
Gram-positive species, attributed to prolific glucosaminidase
activity (20, 21). Previously, the only glucosaminidase charac-
terized in S. aureus was the bifunctional glucosaminidase
N-acetylmuramyl-L-alanine amidase, Atl, thought to be pri-
marily involved in cell division (22, 23).
In this study, we report that a previously uncharacterized en-
zyme, SagB, is the major glucosaminidase for processing of glycan
chains in S. aureus. We unravel the mechanisms connecting the
biochemical activity of glucosaminidases to the mechanical prop-
erties of the cell wall, the cellular morphology and, ultimately, the
capacity of the bacterial cells to enlarge and the population to
grow. We propose that, as previously speculated, modulation of
cell wall mechanical properties by hydrolases is a general mecha-
nism for the enlargement of bacterial cells, with the timing and
synchronicity of insertion and hydrolysis differingwidely between
species.
RESULTS
Shape changes and cell wall alteration throughout the cell cycle.
Cellular morphological dynamics were investigated using fluores-
cence microscopy of living cells stained with FM 1-43 to visualize
the membrane. Of 100 cell cycle events scrutinized in detail, all
cells exhibited a rapid splitting event within the 15-s interval be-
tween camera frames (Fig. 1a). This is consistent with very re-
cently published data showing that this process occurs withinmil-
liseconds and that cell volume increase occurs at a constant rate
throughout the cell cycle, leading to a prolate morphology (13).
The splitting is preceded by the cell surface scission event previ-
ously observed during AFM imaging of cell division (24, 25).
AFM imaging (11) and force measurements (16) indicate that
septalpeptidoglycanchangesas itmatures.To investigate this further,
the accessibility of peptidoglycan to a large peptidoglycan-binding
probewasassessed inS.aureuswild-type strainSH1000cells (Fig. 1b).
Wheat Germ Agglutinin-Alexa Fluor 350 conjugate (WGA-AF350;
heterodimer of approximately 38 kDa) is a GlcNAc-binding lectin.
Although the GlcNAc-MurNAc glycanmotif is ubiquitous, in many
instances, the WGA-AF350 complex labeled only part of the cell.
Comparison with fluorescent vancomycin (Van-FL) labeling, which
binds the pentapeptide that is prevalent in regions of newly inserted
peptidoglycan and is thus amarker of nascent cell wall (26), revealed
that WGA-AF350 preferentially bound the mature cell wall but was
excluded from the septum. This suggests that the architecture of the
nascent cell wall hinders access by the large WGA lectin, whereas in
matured cells, the peptidoglycan is labeled homogenously. In con-
trast, the approximately 22-fold-smaller Van-FL (~1.5 kDa) could
access the nascent peptidoglycan, even when daughter cells were not
separated, further evidence ofmodification of the peptidoglycannet-
work.
Glucosaminidases are critical forpopulationgrowth inS. au-
reus.Given that the short glycan chain length in S. aureus suggests
a major role for glucosaminidases in overall peptidoglycan hy-
drolysis, we hypothesized that inactivation of all glucosamini-
dase activity would have an impact on population growth. Four
enzymes with glucosaminidase activity (known and putative)
were identified by BLAST searches against the known gluco-
saminidase domain of Atl (Fig. 2a; see also Fig. S1 in the sup-
plemental material). Those identified are atl (23) and three
additional glucosaminidase domain-encoding genes, for which
the nomenclature sagA (SACOL2298) and sagB (SACOL1825),
for S. aureus glucosaminidase A and B, respectively, and scaH
(SACOL2666) is proposed. Gene inactivations were made in
each of the four, and every combination of triple mutant con-
Wheeler et al.
2 ® mbio.asm.org July/August 2015 Volume 6 Issue 4 e00660-15
structed in S. aureus SH1000 (Table 1, Table 2, and Table 3).
Despite repeated attempts, we were unable to obtain a strain in
which all four putative glucosaminidase-encoding genes were
inactivated, prompting the hypothesis that glucosaminidase
activity is essential. To test this, a conditional quadruple glu-
cosaminidase mutant was constructed by inserting an induc-
ible sagB expression construct into the SH4611 (atl sagA scaH)
triple mutant background. The resulting strain, SH4615 (Pspac-
sagB atl sagA scaH), contains a truncated copy of sagB under the
control of the native promoter and a full copy of sagB under the
isopropyl--D-thiogalactopyranoside (IPTG)-inducible Pspac
promoter (see Fig. S2 in the supplemental material).
The importance of glucosaminidase activity was assessed by
plating the conditionalmutant on solidmedium in the presence of
1mM IPTG and then streaking single colonies onto solidmedium
with or without IPTG (Fig. 2b). In the absence of IPTG, little
growth was observed. Thus, it is not the individual enzymes that
are required, as they are functionally redundant, but more likely
glucosaminidase activity itself.
Although inactivation of sagB alone did not affect growth on
solidmedium (data not shown), in liquidmedium, inactivation of
sagB alone led to a substantial increase in doubling time [for
SH1000, 30  1 min (mean  standard error), and for SH4608
(sagB), 43  2 min] and yield (see Fig. S3 in the supplemental
material). Strain SH4615 (Pspac-sagB atl sagA scaH) without IPTG
exhibited a longer doubling time (50  4 min) than SH4608
(sagB), SH4611 (atl sagA scaH), and SH4615 (Pspac-sagB atl sagA
scaH) with IPTG.
Cells lacking glucosaminidases have morphological defects.
Exponential-phase cells (optical density at 600 nm [OD600] of
FIG 1 Morphological dynamics during the cell cycle of S. aureus. (a) FM 1-43 labeling of living S. aureus SH1000 cells shows that the bacteria change shape
rapidly immediately after division (see dashed boxes). (b) Images of S. aureus after labeling of the cell wall with Van-FL (~1.7-kDa) andWGA-AF350 (~38-kDa)
fluorescent probe molecules. Arrowheads show cells where Van-FL is bound to regions from which WGA-AF350 has been excluded.
FIG 2 Role of glucosaminidases in population growth. (a) Physical map showing the domain structure of putative glucosaminidases of S. aureus. Percentage
homology to Atl glucosaminidase domain and length of homologous amino acid sequence (aa) are indicated in brackets. Black, signal peptide; green, propeptide;
grey, repeat domains R1, R2, and R3; blue, N-acetyl-muramyl-L-alanine amidase domain; red, N-acetyl--D-glucosaminidase domain; purple, cysteine,
histidine-dependent amidohydrolase/peptidase (CHAP) domain. (b) Growth of SH4615 (Pspac-sagB atl sagA scaH) with or without IPTG.
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~0.3) were labeled with Van-FL prior to fixation, to visualize the
cell wall and plane of septation. In wild-type SH1000, the normal
range of roughly spherical-to-prolate shapeswith orwithout septa
were identified (11). However, in SH4615 (Pspac-sagB atl sagA
scaH) without IPTG, roughly hemispherical cells distinct from
previously observed wild-type morphologies were observed
(Fig. 3a and b). These hemispherical cells were not attached to
their sisters, and in some cases, these were bisected by a nascent
septum despite not yet having expanded into the mature mor-
phology. This shows that normal cellular enlargement has failed to
take place prior to the cell attempting to initiate another round of
division. Hemispherical cells were also observed at lower preva-
FIG 3 Morphological defects in S. aureus cells lacking glucosaminidases. (a) Images of fixed, Van-FL-labeled cells showing altered morphology. Arrowheads
indicate hemispherical cells. Cells of this shape are not found inwild-type populations unless attached to a sister cell. (b) Examples of hemispherical cells. In some
cells, septa are visible in bacteria that have not completed the shape change to themature sphericalmorphology. This shows that correct shape change is not taking
place within the duration of the cell cycle. (c) Quantification of the proportion of hemispherical cells in each sample. P values are the result of Fisher’s exact tests
comparing the wild type with each mutant.
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lence in SH4615 (Pspac-sagB atl sagA scaH) with IPTG and in
SH4611 (atl sagA scaH) (Fig. 3c), suggesting that expression from
the Pspac promoter is insufficient to give native levels of SagB. In
SH4608 (sagB), very few hemispherical cells were observed (see
Fig. S4 in the supplemental material). To summarize, cells im-
paired in glucosaminidase activity are also impaired in their ability
to increase in size after division and adopt the correct mature
shape.
SagBmodulates cell wall elasticity. In order to investigate the
relationship between the ability of cells to enlarge and assume
correct morphology and cell wall mechanical properties, the stiff-
ness of the cell wall was measured using AFM in several gluco-
saminidase mutants. This enabled exploration of the possibility
that increased stiffness (i.e., more force must be applied to result
in the same amount of stretching of the cell wall) is associatedwith
impaired glucosaminidase activity (Fig. 4). With this approach, a
force is applied by an AFM tip to a surface of interest and the
resulting deflection of the cantilever and, thus, indentation of the
cell surface is measured. Bymeasuring the gradient of a tangent to
this force-displacement curve in the region of low deformation, a
relative measure of cell surface stiffness is obtained independently
of overall cell deformation and turgor.More sophisticated contact
mechanics models were not employed for reasons described pre-
viously (16). The measurements were taken frommultiple points
on the surface of the cell (Fig. 4a) in regions not specifically iden-
tified as recently having been part of the septal plate, i.e., regions
lacking ring or spiral surface architecture.
In strains lacking any combination of three glucosaminidase-
encoding genes, the median cell wall stiffness was significantly
increased (Wilcoxon rank sum test) compared with that of the
wild-type strain SH1000 (Fig. 4b; also see Table S1 in the supple-
mental material). In all strains combining other mutations with
sagB, the cell wall stiffness was similar to that of SH4608 (sagB)
cells. SH4611 (atl sagA scaH) cells had cell walls that were stiffer
than those of SH1000 cells but less stiff than the cell walls of any
strain lacking sagB. Chromosomal complementation of the sagB
deletion using the native promoter led to almost complete resto-
ration of wild-type stiffness. Thus, even though SagB has themost
profound role in cell wall stiffness determination, there is an im-
portant contribution from the other three enzymes.
SagB regulates glycan chain length. The bulk properties of a
polymer (such as peptidoglycan) are a consequence of its nano-
scale structure. Glucosaminidases might therefore modify the
mechanical properties of peptidoglycan, making it less stiff,
through reduction of glycan strand length. In order to establish
whether the observed stiffness changes could be ascribed to
altered chain length, we investigated the individual contribu-
tion of each glucosaminidase to glycan chain length regulation,
using size exclusion chromatography to analyze the chain
length of purified N-acetyl[14C]glucosamine ([14C]GlcNAc)-
labeled glycans (Fig. 5; see also Fig. S5 and S6 in the supple-
mental material).
Consistent with previously published data (20, 21), wild-type
S. aureus had predominantly short glycan chains (on average, 6 to
10 dissacharides), with approximately 30% of glycan chains ex-
ceeding 50 dissacharides in length (Fig. 5; see also Fig. S5 and S6 in
the supplemental material). However, inactivation of sagB re-
sulted in a substantial increase in the proportion of long glycan
strands (52.5% had 50 disaccharides). Complementation of
sagB restored the wild-type chain length distribution (32.9% had
50 disaccharides) (Fig. 5).
Of the strains lacking three glucosaminidases, cells of all strains
carrying the sagB inactivation had an increased proportion of long
glycan strands (48.4 to 59.3% had50 disaccharides) (Fig. 5). In
these cases, the proportion was even higher than for SH4608
(sagB). Strains with inactivations in both sagA and sagB have the
highest proportion of long glycans. This suggests a modest addi-
tional impact on chain length from Atl, ScaH, and in particular,
SagA. SH4611 (atl sagA scaH), in which SagB was the sole remain-
ing glucosaminidase, had a glycan chain length distribution sim-
ilar to that of SH1000 (32.5% had50 disaccharides). Thus, SagB
has a dominant enzymatic activity and is the major glucosamini-
dase responsible for the archetypical short glycan chain length of
S. aureus. Furthermore, this activity is nonredundant, as the pres-
FIG 4 Mechanical properties of the S. aureus cell wall. (a) AFM heights and
effective spring constants (stiffness maps) of SH1000 and SH4608 (sagB) de-
rived from force maps. In the height map, regions with a lighter color are
higher than darker regions. In the stiffnessmap, regions with a lighter color are
stiffer than darker regions. Scale bars, 200 nm; height scale, 500 nm; stiffness
scale, 0.010 to 0.018 Nm1. (b) Stiffness of the cell wall of wild-type and
glucosaminidase mutant strains, derived from AFM force maps.
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ence of functional atl, sagA, and scaH did not compensate for sagB
inactivation. The glycan chain length distributions of SH1367
(atl), SH4606 (sagA), and SH4607 (scaH) were similar to that of
SH1000 (see Fig. S5 in the supplemental material). Given the
dominant role of SagB in glycan chain length reduction, its activity
likely masks any more subtle combined, mutually redundant role
of the other three enzymes.
The capability of SagB to hydrolyze peptidoglycan was con-
firmed in vitro (using B. subtilis peptidoglycan as a substrate) by
zymogramassay (see Fig. S7a in the supplementalmaterial). There
was more complete hydrolysis when the assay was carried out at
pH 5 than at pH 7.5. B. subtilis peptidoglycan is a useful and
appropriate substrate, as it has previously been shown to have long
glycan strands compared to those of S. aureus (21). B. subtilis
purified glycan chainswere digestedwith recombinant SagB orAtl
(glucosaminidase domain) and analyzed by size exclusion chro-
matography (see Fig. S7b). Both SagB- and Atl (glucosaminidase
domain)-digestedmaterial had a lowermolecular weight than un-
digested glycan strands.Material digested byAtl (glucosaminidase
domain) had an overall lowermolecular weight than that digested
by SagB. This indicates a partial digestion by SagB compared to the
digestion by Atl (glucosaminidase domain), suggesting a prefer-
ential activity by SagB on longer glycan strands as substrates (i.e.,
an inability to hydrolyze shorter strands).
SagB has a minimal role in cell separation. The effect of hy-
drolase inactivation on cell separation was investigated using flow
cytometry and optical microscopy. Those strains lacking Atl ex-
hibited higher levels of forward scatter than other strains (forward
scatter tends to be higher for larger objects, i.e., larger clumps; see
Fig. S8a in the supplementalmaterial), a finding qualitatively con-
firmed by optical microscopy (see Fig. S8b), suggesting a less im-
portant role in this process for SagA, SagB, and ScaH. However,
the highest level of forward scatter was observed for SH4611 (atl
sagA scaH), demonstrating a combined effect.
DISCUSSION
The group of hydrolases we have studied here exhibit functional
redundancy in terms of population growth, and only by inactivat-
ing sagA, atl, and scaH and depleting sagB expression do we see
that it is critical for the bacteria to retain at least one of the prod-
ucts of these genes. We have also shown that it is only under
conditions where glucosaminidase activity has been effectively re-
moved that S. aureus cells are impaired in their ability to enlarge
normally. It seems clear that this inability to enlarge at the cellular
level explains the population growth defects.
In light of this redundancy, it is surprising to see that SagB is
by far the dominant enzyme in terms of the effect on glycan
chain length. S. aureus has short glycan chains relative to those
of other Gram-positive bacteria for which size exclusion High-
Performance Liquid Chromatography (HPLC) measurements
have been made (20, 21, 27). Our data show that the processivity
of enzymes that insert peptidoglycan into the sacculus by forming
glycosidic bonds (PBP2, MGT, and SgtA [28]) is not responsible
for the predominance of short glycan chains but, instead, that
chains are subsequently processed by SagB. Inactivation of sagB
alone is enough to increase cell surface stiffness, a phenomenon
explicable simply in terms of the dependence of the bulk proper-
ties of a polymer on the number of cross-links between individual
chains; this explanation is supported by the discovery that peptide
cross-linking levels also affect stiffness (29). This establishes a clear
relationship between glycan chain length and cell surface stiffness.
However, inactivation of sagA, atl, and scaH together also led to an
increase in stiffness, although not as great as that caused by inac-
tivation of sagB. This is despite there being no apparent alteration
from the wild-type chain length in SH4611 (atl sagA scaH). We
interpret this as evidence that these hydrolases affect cell surface
stiffness with minimal influence on the overall glycan chain
length, most likely by breaking a small number of bonds, bonds in
specific locations in the chains, or bonds in specific locations
within the sacculus. Nevertheless, active sagB is unable to fully
compensate for their absence. Ultimately, it seems that cellular
enlargement depends on reduction of cell wall stiffness mediated
by hydrolases, with a concomitant alteration to the peptidoglycan
structure and architecture.
While there have been many proposals describing detailed
mechanisms by which peptidoglycan is inserted into the cell wall
during enlargement of bacterial cells, the overarching concept is
that unstressed material is added before parts of the preexisting
FIG 5 Role of glucosaminidase activity in glycan chain length determination
in S. aureus. Strains lacking sagB had substantially longer glycan strands than
did SH1000. The presence or absence of other glucosaminidase-encoding
genes (atl, sagA, and scaH) had minimal effect on strand length. Annotations
show proportions of glycan strands within ranges of numbers of disaccharides
(DS); grey traces show the proportions in SH1000 cells for comparison. To
compensate for the fact that longer glycan strands incorporate more [14C]Gl-
cNAc, radioactivity counts (cpm) were divided by the corresponding theoret-
ical molecular weight (see Materials and Methods). The glycan chain abun-
dance is plotted normalized relative to themaximal ratio between radioactivity
counts and theoretical molecular weight (cpm/MW).
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sacculus are hydrolyzed to enable expansion. We have shown a
mechanistic basis for this in S. aureus, where hydrolysis of pepti-
doglycan modulates the mechanical properties of the cell wall,
which enables irreversible expansion of the cell. A unifying model
across the bacteria can be invoked in which dense, stiff regions of
peptidoglycan are initially formed, becoming less dense and less
stiff as they are hydrolyzed and, thus, enabling enlargement of the
cell surface area; this model is independent of the detailed mech-
anism of monomer insertion and mode of hydrolysis. In E. coli,
the insertion of new peptidoglycan is targeted to less dense, more
porous regions of the cell wall (1, 30) via an established mecha-
nism involving inner and outermembrane proteins (31, 32),mak-
TABLE 1 Strains used in this study
Species Strain Relevant genotype or description Source
E. coli BL21 (DE3) F ompT hsdSB (rBmB) gal dcm (DE3) Novagen
TOP10 FmcrA (mrr-hsdRMS-mcrBC) 80 lacZ M15 lacX74 recA1deoR araD139
(ara-leu)7697 galK rpsL Strr endA1 nupG
Invitrogen
SH3062 BL21(DE3) pET24d sagB overexpression construct
SH3061 E. coli BL21(DE3) pSRC002 36
SH2195 E. coli BL21(DE3) pSRC003 36
S. aureus SH1000 Functional rsbU derivative of 8325-4 37
SH1367 (atl) SH1000 [atl::pAZ106 (ery lin)] 23
SH4091 (atl::spc) SA113 (atl::spc) 38
SH4606 (sagA) SH1000 (sagA::tet) This study
SH4607 (scaH) SH1000 [scaH::tet(M)] This study
SH4608 (sagB) SH1000 (sagB::kan) This study
SH4609 [sagB geh(sagB)]a SH1000 (sagB::kan geh::sagB) This study
SH4610 (atl sagA sagB) SH1000 (atl::pAZ106 sagA::tet sagB::kan) This study
SH4611 (atl sagA scaH) SH1000 [atl::spc sagA::tet scaH::tet(M)] 39; this study
SH4612 (sagA sagB scaH) SH1000 [sagA::tet sagB::kan scaH::tet(M)] This study
SH4613 (atl sagB scaH) SH1000 [atl::pAZ106 sagB::kan scaH::tet(M)] This study
SH4614 (Pspac-sagB) SH1000 (Pspac-sagB) This study
SH4615 (Pspac-sagB atl sagA scaH) SH1000 [Pspac-sagB atl::spc sagA::tet scaH::tet(M)] This study
SH4090 RN4220 (Pspac-sagB Eryr) This study
RN4220 Restriction-deficient derivative of 8325-4 40
RN6911 agr::tet(M) derivative of RN6390 41
B. subtilis 168 HR Wild type Howard Rogers
a Chromosomal sagB complementation construct abbreviated to geh(sagB) in the main text.
TABLE 2 Plasmids used in this study
Plasmid Relevant background/genotype/markers Source
pAZ106 Promoterless transcriptional lacZ fusion vector, used as a lacZ expression reporter plasmid;
Ampr (E. coli), Eryr (S. aureus)
42
pDG1513 Vector carrying tet cassette suitable for selection in Gram-positive bacteria; Minr Tetr 43
pET24d His6 tag overexpression vector; Kanr Novagen
pET24d-SagB pET24d containing the sagB sequence, minus the signal sequence, upstream from the His6 tag
pGL433b Vector carrying kan cassette suitable for selection in Gram-positive bacteria; Kanr J. Garcia-Lara and S. J. Foster,
unpublished data
pInvSA pUC19 containing a 2.4-kb fragment of the region spanning the sagB gene in which the sagB
gene has been inactivated by a 600-bp deletion; Ampr
pMUTIN4 Insertion vector carrying IPTG-inducible Pspac promoter; Ampr (E. coli), Eryr (S. aureus) 44
pRW01 pMUTIN4 insertion vector carrying Pspac promoter and 650-bp fragment of sagB; Ampr (E. coli),
Eryr (S. aureus)
pSA18Kan pMUTIN4 containing EcoRI-BamHI-cut fragment of pInvSA and 1.5 kb Kanr cassette from
pGL433 within disrupted sagB construct at KpnI restriction site; Ampr (E. coli), Eryr
(S. aureus), Kanr
pSA26Min2 pSA26D with tet(M) cassette of S. aureus RN6911 inserted into KpnI site within the scaH gene;
Ampr (E. coli), Eryr (S. aureus), tet(M) resistance gene
pSA26D pMUTIN4 containing 2.7-kb fragment of scaH and ~1 kb of flanking region; Ampr (E. coli), Eryr
(S. aureus)
pSRC002 atl amidase domain overexpression construct 36
pSRC003 atl glucosaminidase domain overexpression construct 36
pKASBAR pUC18 vector containing attP and tet cassette (Ampr Tetr) 45
pKASBAR-sagB pKASBAR containing a 1,357-bp fragment, including the sagB gene and promoter region,
inserted between EcoRI and BamHI restriction sites; pUC19 E. coli cloning vector (Ampr)
NEB
pCR 2.1-TOPO TOPO TA cloning vector; Ampr Kanr Life Technologies
a Ampr, ampicillin resistance; Eryr, erythromycin resistance; Kanr, kanamycin resistance; Tetr, tetracycline resistance; Minr, minocycline resistance.
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ing these regions more dense. Hydrolysis and expansion of these
regions would allow for enlargement. In B. subtilis, the detailed
mechanism of peptidoglycan insertion is less well understood (27,
33), but essential hydrolase activity is required for cell enlarge-
ment (6). All of the proposed growth modes are compatible with
the general principle of reduction in peptidoglycan density and
increase in elasticity through hydrolase activity to enable enlarge-
ment, as demonstrated here for S. aureus.
MATERIALS AND METHODS
Bacterial strains, plasmids, and primers. The S. aureus strains used in
this study are listed in Table 1, plasmids are listed in Table 2, and primers
in Table 3.
Growth conditions and media. All S. aureus strains were grown in
brain heart infusion (BHI) broth at 37°C with aeration at 250 rpm unless
otherwise stated. E. coli and B. subtilis strains were routinely grown in
Luria-Bertani (LB) medium or Nutrient Broth, respectively, at 37°C with
aeration at 250 rpm. For solid media, 1.5% (wt/vol) agar was added.
Where required, selection for antibiotic resistance markers was carried
out using the following concentrations of drugs: Ampr, ampicillin
(100 g/ml); Chlr, chloramphenicol (30 g/ml); Eryr, erythromycin
(5g/ml) with lincomycin (25g/ml); Kanr, kanamycin (50g/ml) with
neomycin (50g/ml); Minr, minocycline (2g/ml); Spcr, spectinomycin
(100 g/ml); Tetr, tetracycline (5 g/ml).
Geneticmodification of bacteria.Transformation by electroporation
of E. coli or the restriction-deficient S. aureus RN4220 strain was per-
formed according to publishedmethods (34, 35). Phage transduction into
the S. aureus SH1000 background using 11 or 85 was carried out as
described previously (23). Details of construction of strains can be found
in Text S1 in the supplemental material.
Overexpression and purification of recombinant enzymes.An over-
night culture was used to inoculate 1 liter of preheated LB containing
appropriate antibiotics for maintenance of the overexpression plasmid to
an OD600 of 0.05. At an OD600 of approximately 0.4, 1 mM IPTG was
added, and the culture incubated for a further 4 h. Cells were harvested by
centrifugation and stored as pellets at80°C. Pellets were freeze-thawed
three times in sodium phosphate buffer and sonicated on ice six times.
Insoluble material was separated by centrifugation at 10,000  g for
30min. The supernatantwas filter sterilized (0.45-mfilters) and purified
using a 5-ml HiTrap column (Amersham) with a BioRad Econo gradient
pump and fraction collector. The His-tagged proteins were eluted from
the column using an isocratic gradient of 5-to-60% 0.5 M imidazole over
30 min. Eluted fractions were analyzed by SDS-PAGE. Fractions contain-
ing overexpressed protein were pooled, transferred to dialysis tubing, and
dialyzed three times in phosphate-buffered saline (PBS) for 18 h in total.
The identities of purified, overexpressed proteins were confirmed by
N-terminal sequencing.
Analysis of autolysin activity by zymograms. The lytic activity of the
recombinant glucosaminidases was investigated by zymogram (23), using
purified cell walls of vegetative B. subtilis as a substrate.
Purification of sacculi. Bacterial cultures were grown to exponential
phase (OD600 of ~0.5), andpeptidoglycan purified as described previously
(11). Briefly, cells were broken by mechanical shearing using a FastPrep
homogenizer (S. aureus) or French press (B. subtilis). Sacculi were ex-
tracted by boiling in SDS (4% wt/vol), Pronase (2 mg/ml) treatment, and
removal of accessory polymers by incubation in hydrofluoric acid
(48% vol/vol) at 4°C for 48 h. Purified sacculi were washed extensively
(at least six times) in water after SDS or hydrofluoric acid treatment.
Long-term storage of sacculi was at 20°C. Radiolabeling with
N-acetyl[14C]glucosamine ([14C]GlcNAc) was carried out as de-
scribed previously (21). Briefly, exponential-phase (OD600 of 0.3) cul-
tures were diluted in 50 ml of prewarmed LB containing 0.185 MBq
[14C]GlcNAc (1.67 TBq/mmol; Hartmann Analytic) and 500 ml of
nonradioactive medium to give a starting OD600 of 0.04. After three
generations, the cells were harvested by centrifugation and sacculi
purified.
Purification of glycan strands.Glycan strands were purified as previ-
ously described (21). Radiolabeled peptidoglycan sacculi were digested by
recombinant S. aureus Atl amidase domain (36). Typically, 1 mg of pep-
TABLE 3 Oligonucleotides used in this study
Primer Sequence (5=–3=)a Restriction site
RW01_F TTTTTTGAATTCAACAATGACCTAAGAGGTGTGGA EcoRI
RW01_R TTTTTTGGATCCCAACCATGCTTTTTAGC BamHI
P1 CGGGCTCTAGATAATCCACACAGCTGGCGTCTTAGC XbaI
P2 CGGCCGGTACCAGGATCTGTTTCGAATAATGATGTTGC KpnI
FD2 CGGCGGGTACCAACATCATTATTCGAAACAGATCCTAG KpnI
RD2 CGGGCAAGCTTTATTTACGTGCAAATGATATTAATC HindIII
FKan GGCGGGGTACCCAGCGAACCATTTGAGG KpnI
RKan GGGGCGGTACCAATTCCTCGTAGGCGCTCGG KpnI
P6 GGGCCGGATCCTTCAAGGTATAGTTTGAGCC BamHI
P7 TATTATGAGCTCTATCGTCGTATTCGGCTTAAG SacI
MinFK3 AACAAGGTACCAATATGCTCTTACGTGCT KpnI
MinRK4 AACAAGGTACCAGAAATATTGAAGCTAGT KpnI
InvF1 GCGCGGGGTACCAGAACATGAAGACTGAAGGAA KpnI
InvR1 GCGCGGGGTACCTTCAATCTTAATGTCGGAT KpnI
SagA-F1 CGACGGATCCTAACGGAACAATACCTACTC BamHI
SagA-R1 ATAACTGCGGCCGCGAGTGACATTCGCTGGGCAG NotI
SagA-F2 CCGGTACCTTCACGATGAGTAATACAGC KpnI
SagA-R2 ACATGAATTCAACCGCAGTACAGTGTTC EcoRI
Tet-NotI ATAACTGCGGCCGCGGATTTTATGACCGATGATGAAG NotI
Tet-KpnI CCGGTACCTGTTATAAAAAAAGGATCAAT KpnI
rSagB_For GCGCCCATGGTATCCGATCAGATATTTTTCAAACATGTT NcoI
rSagB_Rev GCGCCTCGAGCTTATTCAAATGTTTACTGTCATC XhoI
1825C_For TTTTTTGAATTCGGTCAAATTGAAGGCACGAT EcoRI
1825C_Rev TTTTTTGGATCCTTGCATTGGTGGGATTATCA BamHI
Geh_For GAGGTGCTGACAATGATGAAAA
Geh_Rev CCGATTAATTGAAAGAAGTCTGC
a Restriction sites included for cloning purposes are indicated in bold font.
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tidoglycan was digested overnight with Atl at a concentration 5-fold
greater than that required to solubilize more than 90% of the peptidogly-
can. The enzyme was inactivated by boiling (3min), and the supernatants
were collected for further analysis.
Plating efficiency of conditional mutant. A single colony of SH4615
(Pspac-sagB atl sagA scaH) was taken from an agar plate containing 1 mM
IPTG and appropriate antibiotics using a sterile inoculation loop and was
resuspended in 10 ml PBS. A cotton bud was then used to streak this
suspension onto plates containing 1 mM IPTG or lacking IPTG.
Liquid growth of conditionalmutant.Colonies were taken from agar
plates containing appropriate antibiotics [and 1 mM IPTG in the case of
SH4615 (Pspac-sagB atl sagA scaH)] using a sterile inoculation loop. These
were individually resuspended in 1 ml BHI. Subsequently, these suspen-
sions were used to inoculate 50 ml BHI in 250-ml conical flasks to a
calculated OD600 of 0.001, and the flasks were incubated at 37°C with
agitation at 250 rpm, with optical density measurements taken periodi-
cally. Strains were sonicated prior tomeasurements of optical density and
inoculations to reduce the potential effects of clumping.
Time-lapse microscopy. Bacteria were grown overnight at 37°C with
agitation at 250 rpm in BHI and then subcultured to an OD600 of ~0.05
and grown under the same conditions to an OD600 of ~0.3. Subsequently,
2l of this culture was pipetted onto an agarose pad containing 0.5g/ml
FM 1-43 (Molecular Probes), allowed to partially dry, and then topped
with a coverslip before being imaged using a Nikon Eclipse inverted epi-
fluorescence microscope equipped with an incubator used to hold the
experiment at 37°C.
Imaging cells labeled with fluorescent vancomycin or WGA. BHI
medium was used throughout. Strains were sonicated prior to measure-
ments of optical density and inoculations to reduce the potential effects of
clumping. Strains were grown overnight in the presence of appropriate
antibiotics and, in the case of SH4615 (Pspac-sagB atl sagA scaH), 1 mM
IPTG. Starter cultures [containing no antibiotics but with 10MIPTG in
the case of SH4615 (Pspac-sagB atl sagA scaH)]were then inoculated. These
were incubated at 37°C with agitation at 250 rpm until they reached an
OD600 of ~1. A 10-ml sample was then washed once in prewarmed BHI
and used to inoculate cultures from which microscopy samples would be
taken. One millimolar IPTG was added to one culture of SH4615 (Pspac-
sagB atl sagA scaH) to induce the expression of sagB, while another was left
without IPTG. Samples for microscopy were taken from exponential-
phase cultures and then labeled with Van-FL and imaged as previously
described (11). Fluorescent WGA (Molecular Probes) labeling took place
after Van-FL labeling but before fixing cells. Cells were resuspended in
250 l distilled water containing 1 mM CaCl2 and 100 g/ml fluorescent
WGA and then washed three times by centrifugation.
Cell wall stiffness measurements. Cell wall stiffness measurements
were carried out as described previously (16). Briefly, samples of cells of
each strain to be studied were grown to exponential phase and then
washed and immobilized on a microstructure (24). Bacteria were in-
dented repeatedly under BHImedium, a curve from an equivalent inden-
tation on an incompressible material subtracted, and the tangent to the
resulting force versus indentation curves used to derive a relative effective
spring constant to obtain a measure of stiffness.
HPLC separation of glycan strands. Size exclusion chromatography
of glycan strandswas performed as described previously (21, 27). Approx-
imately 20,000 cpm of each radiolabeled glycan strand fraction (corre-
sponding to 50 to 100 g peptidoglycan) was injected in a volume of
200l onto a TSKSW2000 (7.5 by 600 mm) size exclusion HPLC column
(Tosoh) preequilibrated in 100-mM phosphate buffer (pH 6.0). Elution
was carried out at a flow rate of 0.4 ml/min. Radiolabeled glycan strands
were detected with a LabLogic (-Rammodel 4) radio flow detector using
a 1:1 scintillation cocktail and a 100-l solid cell. The gel filtration col-
umns were calibrated as described previously (21), using dextran stan-
dards ranging from 1 kDa to 150 kDa (analytical standard grade for GPC;
Sigma-Aldrich). Analysis of the glycan strand distribution was carried out
as described previously (21).
Flow cytometry analysis Bacteria were incubated overnight with agi-
tation at 37°C. Ten milliliters of fresh BHI was inoculated with 100 l of
overnight culture (dilution of 1:100). Bacteriawere incubated to anOD600
of 0.3 to 0.4 (early exponential phase) and then diluted 1:100 in PBS. The
samples were analyzed by flow cytometry using anAttun autosampler and
imaged using a Novex optical microscope.
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